Table 1. Oral Vaccine for Human Market Size & CAGR: China VS Global, 2019-2030, US$ Million

Table 2. Oral Vaccine for Human Market Restraints

Table 3. Oral Vaccine for Human Market Trends

Table 4. Oral Vaccine for Human Industry Policy

Table 5. Global Oral Vaccine for Human Revenue by Company, 2019-2024, US$ million

Table 6. Global Oral Vaccine for Human Revenue Market Share by Company, 2019-2024

Table 7. Global Oral Vaccine for Human Sales Volume by Company, 2019-2024, (K Units)

Table 8. Global Oral Vaccine for Human Sales Volume Market Share by Company, 2019-2024

Table 9. Global Oral Vaccine for Human Price by Company, 2019-2024, (US$/Unit)

Table 10. Global Oral Vaccine for Human Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Oral Vaccine for Human Mergers & Acquisitions, Expansion Plans

Table 12. Global Oral Vaccine for Human Manufacturers Product Type

Table 13. China Oral Vaccine for Human Revenue by Company, 2019-2024, US$ million

Table 14. China Oral Vaccine for Human Revenue Market Share by Company, 2019-2024

Table 15. China Oral Vaccine for Human Sales Volume by Company, 2019-2024, (K Units)

Table 16. China Oral Vaccine for Human Sales Volume Market Share by Company, 2019-2024

Table 17. China Market, Oral Vaccine for Human Production, Sales, Import and Export, 2019-2030, (K Units)

Table 18. China Oral Vaccine for Human Import & Export Trends

Table 19. Main Sources of China Oral Vaccine for Human Import

Table 20. Export Destination of China Oral Vaccine for Human

Table 21. Global Headquarters and Manufacturing Base of Oral Vaccine for Human Manufacturers

Table 22. Global Major Manufacturers, Oral Vaccine for Human Capacity Expansion and Future Plans

Table 23. Global Oral Vaccine for Human Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)

Table 24. Global Oral Vaccine for Human Production by Region, 2019-2024, (K Units)

Table 25. Global Oral Vaccine for Human Production Forecast by Region, 2023-2029, (K Units)

Table 26. Global Key Players of Oral Vaccine for Human Upstream (Raw Materials)

Table 27. Global Oral Vaccine for Human Typical Customers

Table 28. Oral Vaccine for Human Typical Distributors

Table 29. By Type, Global Oral Vaccine for Human Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 30. By Application, Global Oral Vaccine for Human Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 31. By Region, Global Oral Vaccine for Human Market Size, 2019 VS 2024 VS 2030, US$ Million

Table 32. By Region, Global Oral Vaccine for Human Revenue, 2019-2030, US$ Million

Table 33. By Region, Global Oral Vaccine for Human Sales Volume, 2019-2030, (K Units)

Table 34. By Country, Global Oral Vaccine for Human Revenue & CAGR，2019 VS 2024 VS 2030, US$ Million

Table 35. By Country, Global Oral Vaccine for Human Revenue, 2019-2030, US$ Million

Table 36. By Country, Global Oral Vaccine for Human Revenue Market Share, 2019-2030

Table 37. By Country, Global Oral Vaccine for Human Sales Volume, 2019-2030, (K Units)

Table 38. By Country, Global Oral Vaccine for Human Sales Volume Market Share, 2019-2030

Table 39. Merck Company Information, Head Office, Market Area and Industry Position

Table 40. Merck Oral Vaccine for Human Models, Specifications and Application

Table 41. Merck Oral Vaccine for Human Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 42. Merck Company Profile and Main Business

Table 43. Merck Recent Developments

Table 44. GSK Company Information, Head Office, Market Area and Industry Position

Table 45. GSK Oral Vaccine for Human Models, Specifications and Application

Table 46. GSK Oral Vaccine for Human Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 47. GSK Company Profile and Main Business

Table 48. GSK Recent Developments

Table 49. Sanofi Company Information, Head Office, Market Area and Industry Position

Table 50. Sanofi Oral Vaccine for Human Models, Specifications and Application

Table 51. Sanofi Oral Vaccine for Human Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 52. Sanofi Company Profile and Main Business

Table 53. Sanofi Recent Developments

Table 54. Lanzhou Institute Company Information, Head Office, Market Area and Industry Position

Table 55. Lanzhou Institute Oral Vaccine for Human Models, Specifications and Application

Table 56. Lanzhou Institute Oral Vaccine for Human Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 57. Lanzhou Institute Company Profile and Main Business

Table 58. Lanzhou Institute Recent Developments

Table 59. Serum Institute Company Information, Head Office, Market Area and Industry Position

Table 60. Serum Institute Oral Vaccine for Human Models, Specifications and Application

Table 61. Serum Institute Oral Vaccine for Human Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 62. Serum Institute Company Profile and Main Business

Table 63. Serum Institute Recent Developments

Table 64. Valneva Company Information, Head Office, Market Area and Industry Position

Table 65. Valneva Oral Vaccine for Human Models, Specifications and Application

Table 66. Valneva Oral Vaccine for Human Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 67. Valneva Company Profile and Main Business

Table 68. Valneva Recent Developments

Table 69. Shanghai United Cell Company Information, Head Office, Market Area and Industry Position

Table 70. Shanghai United Cell Oral Vaccine for Human Models, Specifications and Application

Table 71. Shanghai United Cell Oral Vaccine for Human Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 72. Shanghai United Cell Company Profile and Main Business

Table 73. Shanghai United Cell Recent Developments

Table 74. Bibcol Company Information, Head Office, Market Area and Industry Position

Table 75. Bibcol Oral Vaccine for Human Models, Specifications and Application

Table 76. Bibcol Oral Vaccine for Human Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 77. Bibcol Company Profile and Main Business

Table 78. Bibcol Recent Developments

Table 79. PaxVax Company Information, Head Office, Market Area and Industry Position

Table 80. PaxVax Oral Vaccine for Human Models, Specifications and Application

Table 81. PaxVax Oral Vaccine for Human Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 82. PaxVax Company Profile and Main Business

Table 83. PaxVax Recent Developments

Table 84. Vabiotech Company Information, Head Office, Market Area and Industry Position

Table 85. Vabiotech Oral Vaccine for Human Models, Specifications and Application

Table 86. Vabiotech Oral Vaccine for Human Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 87. Vabiotech Company Profile and Main Business

Table 88. Vabiotech Recent Developments

Table 89. Tiantan Biological Company Information, Head Office, Market Area and Industry Position

Table 90. Tiantan Biological Oral Vaccine for Human Models, Specifications and Application

Table 91. Tiantan Biological Oral Vaccine for Human Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 92. Tiantan Biological Company Profile and Main Business

Table 93. Tiantan Biological Recent Developments

Table 94. EuBiologics Company Information, Head Office, Market Area and Industry Position

Table 95. EuBiologics Oral Vaccine for Human Models, Specifications and Application

Table 96. EuBiologics Oral Vaccine for Human Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 97. EuBiologics Company Profile and Main Business

Table 98. EuBiologics Recent Developments

Table 99. Panacea Biotec Ltd Company Information, Head Office, Market Area and Industry Position

Table 100. Panacea Biotec Ltd Oral Vaccine for Human Models, Specifications and Application

Table 101. Panacea Biotec Ltd Oral Vaccine for Human Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 102. Panacea Biotec Ltd Company Profile and Main Business

Table 103. Panacea Biotec Ltd Recent Developments

Table 104. Bio-Med Company Information, Head Office, Market Area and Industry Position

Table 105. Bio-Med Oral Vaccine for Human Models, Specifications and Application

Table 106. Bio-Med Oral Vaccine for Human Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 107. Bio-Med Company Profile and Main Business

Table 108. Bio-Med Recent Developments

Table 109. Halfkin Bio-Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 110. Halfkin Bio-Pharmaceuticals Oral Vaccine for Human Models, Specifications and Application

Table 111. Halfkin Bio-Pharmaceuticals Oral Vaccine for Human Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 112. Halfkin Bio-Pharmaceuticals Company Profile and Main Business

Table 113. Halfkin Bio-Pharmaceuticals Recent Developments

List of Figure

Figure 1. Oral Vaccine for Human Picture

Figure 2. By Revenue, Global Oral Vaccine for Human Market Size and Forecast, 2019-2030, US$ Million

Figure 3. By Sales Volume, Global Oral Vaccine for Human Market Size and Forecast, 2019-2030, (K Units)

Figure 4. Global Oral Vaccine for Human Price Trend, 2019-2030, (US$/Unit)

Figure 5. By Revenue, China Oral Vaccine for Human Market Size and Forecast, 2019-2030, US$ million

Figure 6. By Sales Volume, China Oral Vaccine for Human Market Size and Forecast, 2019-2030, (K Units)

Figure 7. China Oral Vaccine for Human Price Trend, 2019-2030 (US$/Unit)

Figure 8. By Revenue, China Oral Vaccine for Human Share of Global Market, 2019-2030

Figure 9. By Sales Volume, China Oral Vaccine for Human Share of Global Market, 2019-2030

Figure 10. Global Oral Vaccine for Human Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 11. Global Oral Vaccine for Human Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022

Figure 12. China Oral Vaccine for Human Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 13. China Oral Vaccine for Human Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 14. China Oral Vaccine for Human Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024

Figure 15. Chinese Local Players, Proportion of Oral Vaccine for Human Domestic VS Export, 2022

Figure 16. Global Oral Vaccine for Human Capacity, Production and Capacity Utilization, 2019-2030

Figure 17. Global Oral Vaccine for Human Capacity Market Share by Region, 2022 VS 2029

Figure 18. Global Oral Vaccine for Human Production Market Share & Forecast by Region, 2019-2030

Figure 19. Oral Vaccine for Human Industry Chain

Figure 20. Oral Vaccine for Human Procurement Model

Figure 21. Oral Vaccine for Human Sales Model

Figure 22. Oral Vaccine for Human Sales Channels, Direct Sales and Distribution

Figure 23. Rotavirus Vaccine

Figure 24. Cholera Vaccine

Figure 25. Oral Polio Vaccine

Figure 26. Other

Figure 27. By Type, Global Oral Vaccine for Human Revenue, 2019-2030, US$ Million

Figure 28. By Type, Global Oral Vaccine for Human Revenue Market Share, 2019-2030

Figure 29. By Type, Global Oral Vaccine for Human Sales Volume, 2019-2030, (K Units)

Figure 30. By Type, Global Oral Vaccine for Human Sales Volume Market Share, 2019-2030

Figure 31. By Type, Global Oral Vaccine for Human Price, 2019-2030, (US$/Unit)

Figure 32. Public

Figure 33. Private

Figure 34. By Application, Global Oral Vaccine for Human Revenue, 2019-2030, US$ Million

Figure 35. By Application, Global Oral Vaccine for Human Revenue Market Share, 2019-2030

Figure 36. By Application, Global Oral Vaccine for Human Sales Volume, 2019-2030, (K Units)

Figure 37. By Application, Global Oral Vaccine for Human Sales Volume Market Share, 2019-2030

Figure 38. By Application, Global Oral Vaccine for Human Price, 2019-2030, (US$/Unit)

Figure 39. By Region, Global Oral Vaccine for Human Revenue Market Share, 2019-2030

Figure 40. By Region, Global Oral Vaccine for Human Sales Volume Market Share, 2019-2030

Figure 41. North America Oral Vaccine for Human Revenue & Forecasts, 2019-2030, US$ Million

Figure 42. By Country, North America Oral Vaccine for Human Revenue Market Share, 2022

Figure 43. Europe Oral Vaccine for Human Revenue & Forecasts, 2019-2030, US$ Million

Figure 44. By Country, Europe Oral Vaccine for Human Revenue Market Share, 2022

Figure 45. Asia Pacific Oral Vaccine for Human Revenue & Forecasts, 2019-2030, US$ Million

Figure 46. By Country/Region, Asia Pacific Oral Vaccine for Human Revenue Market Share, 2022

Figure 47. South America Oral Vaccine for Human Revenue & Forecasts, 2019-2030, US$ Million

Figure 48. By Country, South America Oral Vaccine for Human Revenue Market Share, 2022

Figure 49. Middle East & Africa Oral Vaccine for Human Revenue & Forecasts, 2019-2030, US$ Million

Figure 50. U.S. Oral Vaccine for Human Sales Volume, 2019-2030, (K Units)

Figure 51. By Company, U.S. Oral Vaccine for Human Market Share, 2022

Figure 52. By Type, U.S. Oral Vaccine for Human Sales Volume Market Share, 2022 VS 2029

Figure 53. By Application, U.S. Oral Vaccine for Human Sales Volume Market Share, 2022 VS 2029

Figure 54. Europe Oral Vaccine for Human Sales Volume, 2019-2030, (K Units)

Figure 55. By Company, Europe Oral Vaccine for Human Market Share, 2022

Figure 56. By Type, Europe Oral Vaccine for Human Sales Volume Market Share, 2022 VS 2029

Figure 57. By Application, Europe Oral Vaccine for Human Sales Volume Market Share, 2022 VS 2029

Figure 58. China Oral Vaccine for Human Sales Volume, 2019-2030, (K Units)

Figure 59. By Company, China Oral Vaccine for Human Market Share, 2022

Figure 60. By Type, China Oral Vaccine for Human Sales Volume Market Share, 2022 VS 2029

Figure 61. By Application, China Oral Vaccine for Human Sales Volume Market Share, 2022 VS 2029

Figure 62. Japan Oral Vaccine for Human Sales Volume, 2019-2030, (K Units)

Figure 63. By Company, Japan Oral Vaccine for Human Market Share, 2022

Figure 64. By Type, Japan Oral Vaccine for Human Sales Volume Market Share, 2022 VS 2029

Figure 65. By Application, Japan Oral Vaccine for Human Sales Volume Market Share, 2022 VS 2029

Figure 66. South Korea Oral Vaccine for Human Sales Volume, 2019-2030, (K Units)

Figure 67. By Company, South Korea Oral Vaccine for Human Market Share, 2022

Figure 68. By Type, South Korea Oral Vaccine for Human Sales Volume Market Share, 2022 VS 2029

Figure 69. By Application, South Korea Oral Vaccine for Human Sales Volume Market Share, 2022 VS 2029

Figure 70. Southeast Asia Oral Vaccine for Human Sales Volume, 2019-2030, (K Units)

Figure 71. By Company, Southeast Asia Oral Vaccine for Human Market Share, 2022

Figure 72. By Type, Southeast Asia Oral Vaccine for Human Sales Volume Market Share, 2022 VS 2029

Figure 73. By Application, Southeast Asia Oral Vaccine for Human Sales Volume Market Share, 2022 VS 2029

Figure 74. India Oral Vaccine for Human Sales Volume, 2019-2030, (K Units)

Figure 75. By Company, India Oral Vaccine for Human Market Share, 2022

Figure 76. By Type, India Oral Vaccine for Human Sales Volume Market Share, 2022 VS 2029

Figure 77. By Application, India Oral Vaccine for Human Sales Volume Market Share, 2022 VS 2029

Figure 78. Middle East & Asia Oral Vaccine for Human Sales Volume, 2019-2030, (K Units)

Figure 79. By Company, Middle East & Asia Oral Vaccine for Human Market Share, 2022

Figure 80. By Type, Middle East & Asia Oral Vaccine for Human Sales Volume Market Share, 2022 VS 2029

Figure 81. By Application, Middle East & Asia Oral Vaccine for Human Sales Volume Market Share, 2022 VS 2029

Figure 82. Research Methodology

Figure 83. Breakdown of Primary Interviews

Figure 84. Bottom-up Approaches

Figure 85. Top-down Approaches